Chemical and Biomolecular Engineering Home > News >Dr. Daniel Heller Seminar Speaker

Daniel HellerFall Seminar Series continues with Dr. Daniel Heller

The Chemical and Biomolecular Engineering is pleased to announce the second speaker in our Fall 2014 Seminar Series. Dr. Daniel Heller from the Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, in New York will be speaking Wednesday, September 17, 2014 in Room B023 in Iacocca Hall at 2:30. Seminars are open to the public and all interested visitors are welcome to attend.

“Nanotechnologies for Biomedical Imaging and Optical Sensors”

The detection and identification of analytes in living biological systems present important goals for next-generation nanoscale sensors. To this end, promising developments in nanomaterials are improving the detection of molecular binding phenomena.  The resulting materials may allow for the quantification of disease biomarkers and other biomolecules in situ.  My research group employs the fluorescence of single-walled carbon nanotubes for molecular imaging and analyte quantification within biological environments.  Semiconducting single-walled carbon nanotubes emit bandgap photoluminescence in the near-IR spectral region and exhibit unique photostability.  To build optical probes using these materials, we developed new imaging techniques to detect nanotube emission in biological environments and new polymers to control their optical properties.  Our goal is to develop new tools to allow biologists to ask previously unanswerable questions and to give clinicians real-time information about their patients.


Dr. Daniel Heller holds the position of Assistant Member at Memorial Sloan-Kettering and Assistant Professor at Weill Cornell Medical College. His work focuses on nanoscale technologies, including optical biosensors for cancer research and diagnosis, and targeted nanoparticles to treat metastatic cancer. Dr. Heller obtained a BA in history from Rice University in 2000 and a PhD in chemistry from the University of Illinois in 2010.  In 2012, he completed a Damon Runyon Postdoctoral Fellowship in the laboratory of Robert Langer at the David H. Koch Institute for Integrative Cancer Research at MIT and is a 2012 recipient of the National Institutes of Health Director’s New Innovator Award. 

Colloquium at 2:30 PM, Room B023, Iacocca Hall - Refreshments at 2:15 PM
Mountaintop Campus, Iacocca Hall, Lehigh University, Bethlehem, PA 18015